PB 82 of 2024
National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 6)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following Determination:
Dated 30 July 2024
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
1 Name
This instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2024 (No. 6).
This instrument may also be cited as PB 82 of 2024.
2 Commencement
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information |
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 August 2024 | |
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
3 Authority
This instrument is made under section 85B of the National Health Act 1953.
4 Schedules
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Schedule 1—Amendments
National Health (Price and Special Patient Contribution) Determination 2022 (PB 98 of 2022)
- Schedule 1 – entry for Fluconazole
Omit
Fluconazole | Capsule 50 mg | Oral | Diflucan | 28 | 5.93 | 9.27 |
| Capsule 100 mg | Oral | Diflucan | 28 | 11.53 | 15.49 |
| Capsule 200 mg | Oral | Diflucan | 28 | 22.47 | 29.13 |
Insert
Fluconazole | Capsule 50 mg | Oral | Diflucan | 28 | 5.93 | 14.54 |
| Capsule 100 mg | Oral | Diflucan | 28 | 11.53 | 15.49 |
| Capsule 200 mg | Oral | Diflucan | 28 | 22.47 | 29.13 |
2. Schedule 1 – after entry for Metformin
Insert
Methyldopa | Tablet 250 mg (as sesquihydrate) | Oral | Aldomet | 100 | 8.18 | 11.05 |
3. Schedule 1 – entry for Olmesartan with amlodipine and hydrochlorothiazide
Omit
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/5/12.5 | 30 | 8.21 | 10.65 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/5/25 | 30 | 9.66 | 12.15 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/10/12.5 | 30 | 8.59 | 12.56 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/10/25 | 30 | 10.02 | 12.50 |
Insert
Olmesartan with amlodipine and hydrochlorothiazide | Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 20/5/12.5 | 30 | 5.57 | 8.36 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/5/12.5 | 30 | 8.21 | 10.65 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/5/25 | 30 | 9.66 | 12.15 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 12.5 mg | Oral | Sevikar HCT 40/10/12.5 | 30 | 8.59 | 12.56 |
| Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besilate) and hydrochlorothiazide 25 mg | Oral | Sevikar HCT 40/10/25 | 30 | 10.02 | 12.50 |
4. Schedule 1 – after entry for Prednisone
Insert
Pregabalin | Capsule 75 mg | Oral | Lyrica | 56 | 5.99 | 10.45 |
| Capsule 150 mg | Oral | Lyrica | 56 | 9.20 | 14.73 |
5. Schedule 1 – entry for Salbutamol
Omit
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Asmol CFC-Free with dose counter | 1 | 5.42 | 5.85 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Ventolin CFC-Free with dose counter | 1 | 5.42 | 7.71 |
Insert
Salbutamol | Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 2.98 | 4.54 |
| Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20 | Inhalation | Ventolin Nebules | 1 | 3.11 | 4.66 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Asmol CFC-Free with dose counter | 1 | 5.42 | 5.85 |
| Pressurised inhalation 100 micrograms (as sulfate) per dose with dose counter, 200 doses (CFC-free formulation) | Inhalation by mouth | Ventolin CFC-Free with dose counter | 1 | 5.42 | 8.21 |
6. Schedule 1 – entry for Sertraline
Omit
Sertraline | Tablet 50 mg (as hydrochloride) | Oral | Zoloft | 30 | 2.50 | 7.90 |
| Tablet 100 mg (as hydrochloride) | Oral | Zoloft | 30 | 2.50 | 7.90 |
Insert
Sertraline | Tablet 50 mg (as hydrochloride) | Oral | Zoloft | 56 | 2.50 | 8.83 |
| Tablet 100 mg (as hydrochloride) | Oral | Zoloft | 56 | 2.50 | 8.83 |